Lithium Hydroxide → HCID 9799156, compound
Reaction equation
C[O:2][C:3](=[O:28])[CH2:4][O:5][C:6]1[C:7]2[C:8]3[CH:24]([C:25](=[O:27])[NH2:26])[CH2:23][CH2:22][C:9]=3[N:10]([CH2:15][C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=3)[C:11]=2[CH:12]=[CH:13][CH:14]=1.[Li+].[OH-]>C1COCC1.CO>[CH2:15]([N:10]1[C:11]2[CH:12]=[CH:13][CH:14]=[C:6]([O:5][CH2:4][C:3]([OH:28])=[O:2])[C:7]=2[C:8]2[CH:24]([C:25](=[O:27])[NH2:26])[CH2:23][CH2:22][C:9]1=2)[C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A slurry of (4-Benzyl-1-carbamoyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-8-yloxy)-acetic acid methyl ester (24 mg; 0.06 mmol) in THF (2 mL) and MeOH (0.7 mL) was treated with 1N aqueous LiOH (0.1 mL). The mixture was stirred for 14 hrs and was concentrated in vacuo. Purification by reverse phase chromatography (Vydac C18column; 5% to 70% of 0.1% HCl/H2O in 0.1% HCl/CH3CN) afforded 21 mg (92%) (4-Benzyl-1-carbamoyl-1,2,3,4-tetrahydro-cyclopenta[b]indol-8-yloxy)-acetic acid, compound 8, Scheme 1, as a white solid. 1H NMR (CDCl3) δ 7.30–7.19 (m, 4H), 7.09 (d, J=7.3 Hz, 2H), 6.98 (d, J=8.8 Hz, 1H), 6.87 (app t, J=7.8 Hz, 1H), 6.67 (br s, 1H), 6.42 (d, J=7.8 Hz, 1H), 5.25 (s, 2H), 4.66–4.51 (m, 2H), 3.85 (d, 7.8 Hz, 1H), 2.96–2.84 (m, 1H), 2.76–2.62 (m, 3H); IR (KBr) 3413, 1716, 1667, 1636, 1614, 1496, 1432, 1256, 1115, 721, 701 cm−1; FDMS, 365 (M+1); Anal calcd for C21H20N2O4.0.5 HCl: C, 64.92; H, 5.40; N, 7.32. Found: C, 64.75; H,5.65; N, 7.13.
Workup
- concentrationwas concentrated in vacuo
- customPurification by reverse phase chromatography (Vydac C18column; 5% to 70% of 0.1% HCl/H2O in 0.1% HCl/CH3CN)
Sources & evidence
- ORD record
- ord-514d0324d241463280ca7394e7a8165d
- Source dataset
- uspto-grants-2007_01
- Patent number
- US07160909B2
Reaction notes
Loading…